Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation

Overview of attention for article published in Clinical Pharmacokinetics, September 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 6,770 followers.

RT @GrupoPKgen_SEFH: PopPK for Dosing of #Melphalan in Hematopoietic Stem Cell Tx --> optimal sampling 0.08, 0.61, 2, 4h post-infusion http…

RT @GrupoPKgen_SEFH: PopPK for Dosing of #Melphalan in Hematopoietic Stem Cell Tx --> optimal sampling 0.08, 0.61, 2, 4h post-infusion http…

RT @GrupoPKgen_SEFH: PopPK for Dosing of #Melphalan in Hematopoietic Stem Cell Tx --> optimal sampling 0.08, 0.61, 2, 4h post-infusion http…

RT @GrupoPKgen_SEFH: PopPK for Dosing of #Melphalan in Hematopoietic Stem Cell Tx --> optimal sampling 0.08, 0.61, 2, 4h post-infusion http…

RT @GrupoPKgen_SEFH: PopPK for Dosing of #Melphalan in Hematopoietic Stem Cell Tx --> optimal sampling 0.08, 0.61, 2, 4h post-infusion http…

RT @GrupoPKgen_SEFH: PopPK for Dosing of #Melphalan in Hematopoietic Stem Cell Tx --> optimal sampling 0.08, 0.61, 2, 4h post-infusion http…

PopPK for Dosing of #Melphalan in Hematopoietic Stem Cell Tx --> optimal sampling 0.08, 0.61, 2, 4h post-infusion https://t.co/kUKTs9zpQg